Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN104045513A reveals cost-effective Empagliflozin intermediate synthesis. Enhances supply chain reliability and reduces manufacturing complexity for global pharmaceutical partners.
Novel NCS TEMPO oxidation method ensures stable scale-up and high purity for pharmaceutical intermediates manufacturing reducing cost and improving supply chain reliability significantly
Efficient iron-catalyzed method for fused ring [1,2-a] indoles. Reduces cost, improves scalability for pharmaceutical intermediate manufacturing.
Patent CN105473546A details a safer synthesis route for R-biphenylalaninol. This method offers cost reduction in API intermediate manufacturing and supply chain reliability.
Advanced preparation method for dexrazoxane via optimized alkylation and cyclization. Reduces inorganic salt waste and eliminates column chromatography for cost-effective manufacturing.
Novel room-temperature asymmetric catalysis for chiral secondary aryl alcohols. Reduces cost by eliminating noble metals. High yield and ee for pharma intermediates.
Patent CN101481363B reveals a novel amidation route for repaglinide intermediates, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN106834372B reveals a novel transaminase method for (S)-2-aminobutanamide. Achieve >99.5% ee and significant cost reduction in API manufacturing with scalable green chemistry.
Novel microchannel nitration process for irinotecan intermediate ensures safety and yield. Supply chain reliability improved via intrinsic safety design and reduced waste discharge for global buyers.
Novel synthesis route for high-purity pharmaceutical intermediate offering safety and scale-up advantages for global supply chains and cost reduction.
Novel Wittig reaction route enhances purity and yield for gefarnate manufacturing, offering significant supply chain stability and cost reduction benefits for global pharmaceutical partners.
Novel 5-step synthesis of ent-chromazonarol from sclarealdehyde. Reduces steps vs prior art. Suitable for industrial scale-up and supply chain stability.
Patent CN101255171A reveals a safer carbapenem intermediate process eliminating toxic organotin. Achieve cost reduction and supply reliability.
Patent CN105399744B reveals optimized Omarigliptin synthesis. High yield and purity benefit supply chain stability and cost reduction significantly.
Novel efficient route for Xiawu Base B via C-H activation. Reduces cost and improves scalability for pharmaceutical manufacturing using accessible raw materials.
Novel crystallization method ensures 99.9% purity for Bilastine. Reduces impurities and enhances stability for reliable pharmaceutical supply chains.
Patent CN119039150A details a novel Negishi coupling route for high-purity Cobicistat intermediates, offering significant supply chain and cost advantages for manufacturers.
Patent CN116554054B reveals efficient styrene-based synthesis for ketoprofen and loxoprofen intermediates offering significant supply chain and cost advantages for pharmaceutical manufacturing.
Novel fragment condensation method for bivalirudin synthesis ensures high purity and yield. Reduces waste and cost for pharmaceutical intermediates manufacturing supply chain.
Patent CN113493405B reveals solid intermediate route for Milrinone. Enhances purity and safety for scalable pharmaceutical intermediate manufacturing supply chains.